Renal Artery Revascularization

Authors:

Abstract
Arguments for renal artery revascularization include blood pressure control, stabilization of renal function, and reduction in adverse cardiovascular events. We previously reported on the randomized clinical trial data to 2009 regarding renal artery revascularization compared with medical therapy.1 That report concluded that renal artery revascularization was associated with marginal improvement in serum creatinine levels (P = .06) and no improvement in systolic blood pressure (P = .32), although there was need for fewer antihypertensive medications (P < .001). Since then, the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) Trial has been published.2